

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 6.08454927 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 6.08454927 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.56950713 |
| 4 | protein retention in ER lumen (GO:0006621) | 4.55358971 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.11149357 |
| 6 | fatty acid elongation (GO:0030497) | 4.10844659 |
| 7 | GDP-mannose metabolic process (GO:0019673) | 4.06893027 |
| 8 | signal peptide processing (GO:0006465) | 4.03010557 |
| 9 | proteasome assembly (GO:0043248) | 4.02921767 |
| 10 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.87896683 |
| 11 | type B pancreatic cell proliferation (GO:0044342) | 3.87335315 |
| 12 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.85773031 |
| 13 | ER overload response (GO:0006983) | 3.71858326 |
| 14 | nuclear envelope reassembly (GO:0031468) | 3.66589668 |
| 15 | mitotic nuclear envelope reassembly (GO:0007084) | 3.66589668 |
| 16 | positive regulation of mitochondrial fission (GO:0090141) | 3.57291024 |
| 17 | iron-sulfur cluster assembly (GO:0016226) | 3.56318871 |
| 18 | metallo-sulfur cluster assembly (GO:0031163) | 3.56318871 |
| 19 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.52748916 |
| 20 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.45453416 |
| 21 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.45453416 |
| 22 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.43629776 |
| 23 | protein deneddylation (GO:0000338) | 3.41273139 |
| 24 | central nervous system myelination (GO:0022010) | 3.35782639 |
| 25 | axon ensheathment in central nervous system (GO:0032291) | 3.35782639 |
| 26 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.34256223 |
| 27 | ATP synthesis coupled proton transport (GO:0015986) | 3.34256223 |
| 28 | respiratory electron transport chain (GO:0022904) | 3.25781979 |
| 29 | transferrin transport (GO:0033572) | 3.25443935 |
| 30 | cullin deneddylation (GO:0010388) | 3.25089619 |
| 31 | protein neddylation (GO:0045116) | 3.24791190 |
| 32 | electron transport chain (GO:0022900) | 3.19333369 |
| 33 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.18973957 |
| 34 | phagosome maturation (GO:0090382) | 3.18928427 |
| 35 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.17191212 |
| 36 | presynaptic membrane assembly (GO:0097105) | 3.14715890 |
| 37 | ferric iron transport (GO:0015682) | 3.14036328 |
| 38 | trivalent inorganic cation transport (GO:0072512) | 3.14036328 |
| 39 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.12666549 |
| 40 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.11277504 |
| 41 | negative regulation of ligase activity (GO:0051352) | 3.11277504 |
| 42 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.11221978 |
| 43 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.10329064 |
| 44 | positive regulation of actin filament depolymerization (GO:0030836) | 3.06748877 |
| 45 | COPII vesicle coating (GO:0048208) | 3.03659905 |
| 46 | extracellular fibril organization (GO:0043206) | 3.03359535 |
| 47 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.03340422 |
| 48 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.01487219 |
| 49 | neuron cell-cell adhesion (GO:0007158) | 3.00791058 |
| 50 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.97874382 |
| 51 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.97874382 |
| 52 | cell adhesion mediated by integrin (GO:0033627) | 2.94735660 |
| 53 | aldehyde catabolic process (GO:0046185) | 2.92867229 |
| 54 | negative regulation of neurotransmitter transport (GO:0051589) | 2.89539647 |
| 55 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.88701319 |
| 56 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.88701319 |
| 57 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.88701319 |
| 58 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.88513151 |
| 59 | regulation of autophagic vacuole assembly (GO:2000785) | 2.87458958 |
| 60 | UV protection (GO:0009650) | 2.87149149 |
| 61 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.86015460 |
| 62 | pH reduction (GO:0045851) | 2.85908679 |
| 63 | skin morphogenesis (GO:0043589) | 2.85606852 |
| 64 | regulation of metalloenzyme activity (GO:0048552) | 2.85407546 |
| 65 | positive regulation of protein targeting to membrane (GO:0090314) | 2.83837477 |
| 66 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.83703059 |
| 67 | adhesion of symbiont to host cell (GO:0044650) | 2.83069668 |
| 68 | virion attachment to host cell (GO:0019062) | 2.83069668 |
| 69 | presynaptic membrane organization (GO:0097090) | 2.82689645 |
| 70 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.81383146 |
| 71 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.81080385 |
| 72 | macroautophagy (GO:0016236) | 2.80947385 |
| 73 | vesicle coating (GO:0006901) | 2.80786781 |
| 74 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.80412870 |
| 75 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.77652449 |
| 76 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.76035913 |
| 77 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.76035913 |
| 78 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.74739752 |
| 79 | regulation of cellular amine metabolic process (GO:0033238) | 2.74140494 |
| 80 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.72307286 |
| 81 | 4-hydroxyproline metabolic process (GO:0019471) | 2.71667129 |
| 82 | positive regulation of TOR signaling (GO:0032008) | 2.70471700 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.70034495 |
| 84 | regulation of protein targeting to membrane (GO:0090313) | 2.68558124 |
| 85 | peptidyl-proline hydroxylation (GO:0019511) | 2.68001293 |
| 86 | coenzyme catabolic process (GO:0009109) | 2.66564068 |
| 87 | actin filament depolymerization (GO:0030042) | 2.65210630 |
| 88 | intracellular pH reduction (GO:0051452) | 2.64796878 |
| 89 | nucleotide transmembrane transport (GO:1901679) | 2.63868170 |
| 90 | protein complex biogenesis (GO:0070271) | 2.62972460 |
| 91 | response to gravity (GO:0009629) | 2.62283243 |
| 92 | regulation of cilium movement (GO:0003352) | 2.61100081 |
| 93 | chaperone-mediated protein transport (GO:0072321) | 2.58437078 |
| 94 | protein targeting to mitochondrion (GO:0006626) | 2.58047845 |
| 95 | negative regulation of JUN kinase activity (GO:0043508) | 2.57921501 |
| 96 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.57014438 |
| 97 | substantia nigra development (GO:0021762) | 2.55898415 |
| 98 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.55825433 |
| 99 | cholesterol biosynthetic process (GO:0006695) | 2.53723922 |
| 100 | dopamine biosynthetic process (GO:0042416) | 2.52919597 |
| 101 | platelet dense granule organization (GO:0060155) | 2.52800797 |
| 102 | C-terminal protein lipidation (GO:0006501) | 2.52487501 |
| 103 | protein hydroxylation (GO:0018126) | 2.52345735 |
| 104 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.51145081 |
| 105 | termination of RNA polymerase III transcription (GO:0006386) | 2.51145081 |
| 106 | fibril organization (GO:0097435) | 2.50348915 |
| 107 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.50322869 |
| 108 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.49242165 |
| 109 | response to redox state (GO:0051775) | 2.48219596 |
| 110 | cofactor catabolic process (GO:0051187) | 2.45815962 |
| 111 | hydrogen ion transmembrane transport (GO:1902600) | 2.45573503 |
| 112 | de novo posttranslational protein folding (GO:0051084) | 2.44594417 |
| 113 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.42695460 |
| 114 | establishment of protein localization to mitochondrion (GO:0072655) | 2.42280932 |
| 115 | L-serine transport (GO:0015825) | 2.41651058 |
| 116 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.40934968 |
| 117 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.40761299 |
| 118 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.40204287 |
| 119 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.39961191 |
| 120 | NADH dehydrogenase complex assembly (GO:0010257) | 2.39961191 |
| 121 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.39961191 |
| 122 | galactose catabolic process (GO:0019388) | 2.39818698 |
| 123 | copper ion homeostasis (GO:0055070) | 2.39794008 |
| 124 | positive regulation of ligase activity (GO:0051351) | 2.38618743 |
| 125 | lipopolysaccharide metabolic process (GO:0008653) | 2.38413150 |
| 126 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.37157018 |
| 127 | barbed-end actin filament capping (GO:0051016) | 2.36260502 |
| 128 | regulation of vacuole organization (GO:0044088) | 2.35731610 |
| 129 | regulation of dopamine metabolic process (GO:0042053) | 2.35583192 |
| 130 | regulation of catecholamine metabolic process (GO:0042069) | 2.35583192 |
| 131 | proton transport (GO:0015992) | 2.35545856 |
| 132 | peptidyl-proline modification (GO:0018208) | 2.35278242 |
| 133 | galactose metabolic process (GO:0006012) | 2.35037901 |
| 134 | isoprenoid biosynthetic process (GO:0008299) | 2.34616524 |
| 135 | heart process (GO:0003015) | 2.34261963 |
| 136 | heart contraction (GO:0060047) | 2.34261963 |
| 137 | limb bud formation (GO:0060174) | 2.31147780 |
| 138 | short-term memory (GO:0007614) | 2.31085933 |
| 139 | photoreceptor cell differentiation (GO:0046530) | 2.30689377 |
| 140 | eye photoreceptor cell differentiation (GO:0001754) | 2.30689377 |
| 141 | hydrogen transport (GO:0006818) | 2.30337694 |
| 142 | adhesion of symbiont to host (GO:0044406) | 2.29479966 |
| 143 | mannosylation (GO:0097502) | 2.28102377 |
| 144 | glycosylceramide metabolic process (GO:0006677) | 2.24985511 |
| 145 | amyloid precursor protein catabolic process (GO:0042987) | 2.23963208 |
| 146 | neuronal action potential propagation (GO:0019227) | 2.22751551 |
| 147 | sterol biosynthetic process (GO:0016126) | 2.21107335 |
| 148 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.19744796 |
| 149 | regulation of collateral sprouting (GO:0048670) | 2.19470837 |
| 150 | positive regulation of amino acid transport (GO:0051957) | 2.19294602 |
| 151 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.17611501 |
| 152 | membrane assembly (GO:0071709) | 2.17202705 |
| 153 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.17034645 |
| 154 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.15124640 |
| 155 | iron ion transport (GO:0006826) | 2.14853306 |
| 156 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.14442248 |
| 157 | amyloid precursor protein metabolic process (GO:0042982) | 2.13354522 |
| 158 | myelination (GO:0042552) | 2.11390278 |
| 159 | axon ensheathment (GO:0008366) | 2.11049973 |
| 160 | ensheathment of neurons (GO:0007272) | 2.11049973 |
| 161 | cellular copper ion homeostasis (GO:0006878) | 2.10806649 |
| 162 | negative regulation of protein localization to cell surface (GO:2000009) | 2.10773384 |
| 163 | GTP biosynthetic process (GO:0006183) | 2.09099928 |
| 164 | heme transport (GO:0015886) | 2.08892298 |
| 165 | nucleotide transport (GO:0006862) | 2.08308143 |
| 166 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.07485887 |
| 167 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.07461620 |
| 168 | protein maturation by protein folding (GO:0022417) | 2.05953147 |
| 169 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.04620955 |
| 170 | L-phenylalanine catabolic process (GO:0006559) | 2.04620955 |
| 171 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.04209910 |
| 172 | response to dietary excess (GO:0002021) | 2.04078396 |
| 173 | eosinophil chemotaxis (GO:0048245) | 2.03810785 |
| 174 | regulation of glutamate secretion (GO:0014048) | 2.03708045 |
| 175 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.02642271 |
| 176 | cellular iron ion homeostasis (GO:0006879) | 2.02526300 |
| 177 | negative regulation of acute inflammatory response (GO:0002674) | 2.02442142 |
| 178 | glycerophospholipid catabolic process (GO:0046475) | 2.01951568 |
| 179 | synaptic vesicle exocytosis (GO:0016079) | 2.01510338 |
| 180 | peptide hormone processing (GO:0016486) | 2.01223895 |
| 181 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.00002666 |
| 182 | glycosphingolipid catabolic process (GO:0046479) | 1.99164516 |
| 183 | positive regulation of synapse assembly (GO:0051965) | 1.99036317 |
| 184 | purine ribonucleotide transport (GO:0015868) | 1.98776367 |
| 185 | magnesium ion transport (GO:0015693) | 1.97201376 |
| 186 | positive regulation of action potential (GO:0045760) | 1.95552513 |
| 187 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 1.95511049 |
| 188 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 1.95511049 |
| 189 | glycolipid catabolic process (GO:0019377) | 1.94957155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 6.07259244 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.49577716 |
| 3 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.71208214 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.56687672 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.51647015 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.08347452 |
| 7 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.04799227 |
| 8 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.88444210 |
| 9 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.55523296 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.36939380 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.21605187 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.14702826 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.14650402 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.14478443 |
| 15 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.14309735 |
| 16 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.13251187 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.11144385 |
| 18 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.10633532 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.10431255 |
| 20 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.09321238 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.05366955 |
| 22 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.01202400 |
| 23 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.01103192 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.00967849 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.99895104 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.98235936 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.96870426 |
| 28 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.95584752 |
| 29 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.94185790 |
| 30 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.93535570 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.93244192 |
| 32 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.92357560 |
| 33 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.91792748 |
| 34 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.91792748 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.91673133 |
| 36 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.90543031 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85059454 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.83556704 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.82578880 |
| 40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.82300042 |
| 41 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.82085455 |
| 42 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.81860804 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.81150339 |
| 44 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.79183228 |
| 45 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.77670554 |
| 46 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.74378789 |
| 47 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.74355091 |
| 48 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.71406057 |
| 49 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.69510429 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68929942 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.67624508 |
| 52 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.67476654 |
| 53 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.65765735 |
| 54 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.65428629 |
| 55 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.64045651 |
| 56 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.63407529 |
| 57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.63164601 |
| 58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.62946148 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.62147726 |
| 60 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.61893206 |
| 61 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.61531942 |
| 62 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.60768398 |
| 63 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.60768398 |
| 64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59705224 |
| 65 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.57993063 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54580951 |
| 67 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54080539 |
| 68 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.48315078 |
| 69 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.48256343 |
| 70 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.45919304 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45651557 |
| 72 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.44972110 |
| 73 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.42948448 |
| 74 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.42267326 |
| 75 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.40288120 |
| 76 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.40020669 |
| 77 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.39352258 |
| 78 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.39189960 |
| 79 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.39107210 |
| 80 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37653145 |
| 81 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.36618995 |
| 82 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.32610224 |
| 83 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.31691505 |
| 84 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.30771472 |
| 85 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30266429 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.29174606 |
| 87 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.28429663 |
| 88 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28406402 |
| 89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.27172806 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.25662574 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23566001 |
| 92 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.22956436 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22814755 |
| 94 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.22724035 |
| 95 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22314269 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21708310 |
| 97 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.21340293 |
| 98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20605455 |
| 99 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20106082 |
| 100 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.18977789 |
| 101 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.17624156 |
| 102 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16698459 |
| 103 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16480783 |
| 104 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16290931 |
| 105 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15870985 |
| 106 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.13921607 |
| 107 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.12844585 |
| 108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12321512 |
| 109 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12147826 |
| 110 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.11076749 |
| 111 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.10509928 |
| 112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09883716 |
| 113 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.08701378 |
| 114 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.08580077 |
| 115 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08191593 |
| 116 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08060602 |
| 117 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07977418 |
| 118 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07332869 |
| 119 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.06926199 |
| 120 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06876930 |
| 121 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.06383987 |
| 122 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.06147014 |
| 123 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05990102 |
| 124 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.05307068 |
| 125 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05283668 |
| 126 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05012681 |
| 127 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04251626 |
| 128 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04035442 |
| 129 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.03998612 |
| 130 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.03946280 |
| 131 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.03600386 |
| 132 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03365638 |
| 133 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03337974 |
| 134 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02993148 |
| 135 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02889330 |
| 136 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.02743409 |
| 137 | JUN_21703547_ChIP-Seq_K562_Human | 1.01772203 |
| 138 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01315560 |
| 139 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00540586 |
| 140 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00527661 |
| 141 | CJUN_26792858_Chip-Seq_BT549_Human | 1.00138195 |
| 142 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.99392768 |
| 143 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.99368585 |
| 144 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99196997 |
| 145 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.99190500 |
| 146 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98714825 |
| 147 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98498590 |
| 148 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97171783 |
| 149 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97157230 |
| 150 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95814359 |
| 151 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.95307537 |
| 152 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95210249 |
| 153 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.94690573 |
| 154 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.94181737 |
| 155 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.94181737 |
| 156 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.93825382 |
| 157 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.93397337 |
| 158 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.93317717 |
| 159 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.93277709 |
| 160 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.92901091 |
| 161 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.92550316 |
| 162 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91918976 |
| 163 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91525998 |
| 164 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91273332 |
| 165 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90893743 |
| 166 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.90891158 |
| 167 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.90883478 |
| 168 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90742425 |
| 169 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.90179847 |
| 170 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.89644119 |
| 171 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88729881 |
| 172 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.88102330 |
| 173 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87835191 |
| 174 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.87554505 |
| 175 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.87147023 |
| 176 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86996233 |
| 177 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.86924225 |
| 178 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86894937 |
| 179 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.86390770 |
| 180 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.86345723 |
| 181 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.85978012 |
| 182 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85882861 |
| 183 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85568194 |
| 184 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85248353 |
| 185 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.85221053 |
| 186 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85087813 |
| 187 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84827150 |
| 188 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.84698856 |
| 189 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.84355790 |
| 190 | FUS_26573619_Chip-Seq_HEK293_Human | 0.84303355 |
| 191 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84245261 |
| 192 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83189739 |
| 193 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.82765715 |
| 194 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.82304531 |
| 195 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81720605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010386_abnormal_urinary_bladder | 3.46922439 |
| 2 | MP0003880_abnormal_central_pattern | 3.30346410 |
| 3 | MP0006054_spinal_hemorrhage | 3.16309815 |
| 4 | MP0000013_abnormal_adipose_tissue | 2.72649473 |
| 5 | MP0003183_abnormal_peptide_metabolism | 2.66148929 |
| 6 | MP0010030_abnormal_orbit_morphology | 2.62747085 |
| 7 | MP0005257_abnormal_intraocular_pressure | 2.62377545 |
| 8 | MP0003279_aneurysm | 2.58810155 |
| 9 | MP0009840_abnormal_foam_cell | 2.49949099 |
| 10 | MP0003186_abnormal_redox_activity | 2.45032056 |
| 11 | MP0001905_abnormal_dopamine_level | 2.40488075 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.39544965 |
| 13 | MP0006276_abnormal_autonomic_nervous | 2.35110261 |
| 14 | MP0000920_abnormal_myelination | 2.24792081 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.15712396 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.14758119 |
| 17 | MP0000750_abnormal_muscle_regeneration | 2.14080608 |
| 18 | MP0002876_abnormal_thyroid_physiology | 2.00847559 |
| 19 | MP0002822_catalepsy | 1.99280162 |
| 20 | MP0005410_abnormal_fertilization | 1.96398580 |
| 21 | MP0004270_analgesia | 1.85394923 |
| 22 | MP0002064_seizures | 1.85134149 |
| 23 | MP0003195_calcinosis | 1.83082786 |
| 24 | MP0003329_amyloid_beta_deposits | 1.77383705 |
| 25 | MP0001968_abnormal_touch/_nociception | 1.76697994 |
| 26 | MP0001542_abnormal_bone_strength | 1.76560851 |
| 27 | MP0002295_abnormal_pulmonary_circulatio | 1.73560705 |
| 28 | MP0002736_abnormal_nociception_after | 1.71294425 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.70302770 |
| 30 | MP0003122_maternal_imprinting | 1.70121820 |
| 31 | MP0009046_muscle_twitch | 1.68405178 |
| 32 | MP0000749_muscle_degeneration | 1.65426808 |
| 33 | MP0002272_abnormal_nervous_system | 1.63724015 |
| 34 | MP0002735_abnormal_chemical_nociception | 1.63234315 |
| 35 | MP0009745_abnormal_behavioral_response | 1.63189456 |
| 36 | MP0000343_altered_response_to | 1.62374983 |
| 37 | MP0002653_abnormal_ependyma_morphology | 1.60101271 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 1.58999995 |
| 39 | MP0003136_yellow_coat_color | 1.55636792 |
| 40 | MP0002733_abnormal_thermal_nociception | 1.54540241 |
| 41 | MP0005379_endocrine/exocrine_gland_phen | 1.51081296 |
| 42 | MP0001440_abnormal_grooming_behavior | 1.49177029 |
| 43 | MP0003690_abnormal_glial_cell | 1.47768099 |
| 44 | MP0004272_abnormal_basement_membrane | 1.46440452 |
| 45 | MP0002163_abnormal_gland_morphology | 1.45659318 |
| 46 | MP0001970_abnormal_pain_threshold | 1.44221289 |
| 47 | MP0008789_abnormal_olfactory_epithelium | 1.42774369 |
| 48 | MP0000751_myopathy | 1.42448354 |
| 49 | MP0003635_abnormal_synaptic_transmissio | 1.41370608 |
| 50 | MP0002572_abnormal_emotion/affect_behav | 1.41337198 |
| 51 | MP0009780_abnormal_chondrocyte_physiolo | 1.39783826 |
| 52 | MP0004233_abnormal_muscle_weight | 1.38447778 |
| 53 | MP0008260_abnormal_autophagy | 1.38040551 |
| 54 | MP0005508_abnormal_skeleton_morphology | 1.36870430 |
| 55 | MP0004043_abnormal_pH_regulation | 1.36221899 |
| 56 | MP0001501_abnormal_sleep_pattern | 1.35628766 |
| 57 | MP0000604_amyloidosis | 1.35311296 |
| 58 | MP0005171_absent_coat_pigmentation | 1.35246354 |
| 59 | MP0004142_abnormal_muscle_tone | 1.32872217 |
| 60 | MP0000538_abnormal_urinary_bladder | 1.32643049 |
| 61 | MP0001529_abnormal_vocalization | 1.32268031 |
| 62 | MP0005165_increased_susceptibility_to | 1.27876583 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.27244129 |
| 64 | MP0003634_abnormal_glial_cell | 1.23327072 |
| 65 | MP0004742_abnormal_vestibular_system | 1.23316938 |
| 66 | MP0000762_abnormal_tongue_morphology | 1.22625821 |
| 67 | MP0002282_abnormal_trachea_morphology | 1.21668296 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.21078402 |
| 69 | MP0005503_abnormal_tendon_morphology | 1.21051474 |
| 70 | MP0000358_abnormal_cell_content/ | 1.19152503 |
| 71 | MP0003786_premature_aging | 1.18898895 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.17776324 |
| 73 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16641598 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 1.16338893 |
| 75 | MP0005408_hypopigmentation | 1.15142243 |
| 76 | MP0005394_taste/olfaction_phenotype | 1.13623547 |
| 77 | MP0005499_abnormal_olfactory_system | 1.13623547 |
| 78 | MP0000516_abnormal_urinary_system | 1.13542828 |
| 79 | MP0005367_renal/urinary_system_phenotyp | 1.13542828 |
| 80 | MP0005197_abnormal_uvea_morphology | 1.13316009 |
| 81 | MP0002332_abnormal_exercise_endurance | 1.13130860 |
| 82 | MP0000681_abnormal_thyroid_gland | 1.10927537 |
| 83 | MP0002063_abnormal_learning/memory/cond | 1.10528027 |
| 84 | MP0003724_increased_susceptibility_to | 1.10405825 |
| 85 | MP0000778_abnormal_nervous_system | 1.09191460 |
| 86 | MP0001727_abnormal_embryo_implantation | 1.08896214 |
| 87 | MP0006082_CNS_inflammation | 1.08626088 |
| 88 | MP0005023_abnormal_wound_healing | 1.08531872 |
| 89 | MP0009379_abnormal_foot_pigmentation | 1.08077556 |
| 90 | MP0005164_abnormal_response_to | 1.07755041 |
| 91 | MP0002090_abnormal_vision | 1.05659542 |
| 92 | MP0002067_abnormal_sensory_capabilities | 1.05312614 |
| 93 | MP0009384_cardiac_valve_regurgitation | 1.02837029 |
| 94 | MP0001486_abnormal_startle_reflex | 1.01613260 |
| 95 | MP0001243_abnormal_dermal_layer | 1.01339120 |
| 96 | MP0001299_abnormal_eye_distance/ | 1.00632025 |
| 97 | MP0005332_abnormal_amino_acid | 0.99863147 |
| 98 | MP0003705_abnormal_hypodermis_morpholog | 0.99476193 |
| 99 | MP0005409_darkened_coat_color | 0.97781199 |
| 100 | MP0002896_abnormal_bone_mineralization | 0.96728009 |
| 101 | MP0003950_abnormal_plasma_membrane | 0.95626467 |
| 102 | MP0008004_abnormal_stomach_pH | 0.95563705 |
| 103 | MP0003011_delayed_dark_adaptation | 0.94674588 |
| 104 | MP0003075_altered_response_to | 0.94346536 |
| 105 | MP0000003_abnormal_adipose_tissue | 0.94188027 |
| 106 | MP0002102_abnormal_ear_morphology | 0.93346609 |
| 107 | MP0005645_abnormal_hypothalamus_physiol | 0.92020040 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.91868922 |
| 109 | MP0004859_abnormal_synaptic_plasticity | 0.91680406 |
| 110 | MP0000462_abnormal_digestive_system | 0.91660868 |
| 111 | MP0005595_abnormal_vascular_smooth | 0.90636720 |
| 112 | MP0002229_neurodegeneration | 0.89344094 |
| 113 | MP0004134_abnormal_chest_morphology | 0.88368525 |
| 114 | MP0004858_abnormal_nervous_system | 0.85038325 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.84763772 |
| 116 | MP0003633_abnormal_nervous_system | 0.83111010 |
| 117 | MP0009250_abnormal_appendicular_skeleto | 0.82371893 |
| 118 | MP0005636_abnormal_mineral_homeostasis | 0.82144502 |
| 119 | MP0003172_abnormal_lysosome_physiology | 0.82108326 |
| 120 | MP0000372_irregular_coat_pigmentation | 0.82032581 |
| 121 | MP0005330_cardiomyopathy | 0.81485055 |
| 122 | MP0001958_emphysema | 0.81465719 |
| 123 | MP0001188_hyperpigmentation | 0.80523812 |
| 124 | MP0002060_abnormal_skin_morphology | 0.80404235 |
| 125 | MP0005551_abnormal_eye_electrophysiolog | 0.80116316 |
| 126 | MP0001533_abnormal_skeleton_physiology | 0.80116028 |
| 127 | MP0005623_abnormal_meninges_morphology | 0.79922130 |
| 128 | MP0006035_abnormal_mitochondrial_morpho | 0.79366742 |
| 129 | MP0002184_abnormal_innervation | 0.78913835 |
| 130 | MP0002066_abnormal_motor_capabilities/c | 0.78066683 |
| 131 | MP0003631_nervous_system_phenotype | 0.77695873 |
| 132 | MP0009697_abnormal_copulation | 0.77537876 |
| 133 | MP0005275_abnormal_skin_tensile | 0.77083828 |
| 134 | MP0002693_abnormal_pancreas_physiology | 0.76333048 |
| 135 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75507810 |
| 136 | MP0001664_abnormal_digestion | 0.75283896 |
| 137 | MP0002177_abnormal_outer_ear | 0.74413559 |
| 138 | MP0005386_behavior/neurological_phenoty | 0.73813643 |
| 139 | MP0004924_abnormal_behavior | 0.73813643 |
| 140 | MP0003385_abnormal_body_wall | 0.73557409 |
| 141 | MP0002148_abnormal_hypersensitivity_rea | 0.73532052 |
| 142 | MP0004147_increased_porphyrin_level | 0.73136934 |
| 143 | MP0002557_abnormal_social/conspecific_i | 0.73134281 |
| 144 | MP0005193_abnormal_anterior_eye | 0.73108096 |
| 145 | MP0000163_abnormal_cartilage_morphology | 0.73069985 |
| 146 | MP0006036_abnormal_mitochondrial_physio | 0.72326034 |
| 147 | MP0004510_myositis | 0.71905304 |
| 148 | MP0001346_abnormal_lacrimal_gland | 0.71707075 |
| 149 | MP0003806_abnormal_nucleotide_metabolis | 0.71693812 |
| 150 | MP0000858_altered_metastatic_potential | 0.71164890 |
| 151 | MP0005166_decreased_susceptibility_to | 0.68129070 |
| 152 | MP0002938_white_spotting | 0.67923226 |
| 153 | MP0001879_abnormal_lymphatic_vessel | 0.67607339 |
| 154 | MP0009764_decreased_sensitivity_to | 0.66648994 |
| 155 | MP0003137_abnormal_impulse_conducting | 0.66202770 |
| 156 | MP0001984_abnormal_olfaction | 0.65835002 |
| 157 | MP0005390_skeleton_phenotype | 0.65815688 |
| 158 | MP0003755_abnormal_palate_morphology | 0.61008887 |
| 159 | MP0005365_abnormal_bile_salt | 0.59487100 |
| 160 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57356316 |
| 161 | MP0000049_abnormal_middle_ear | 0.56981888 |
| 162 | MP0000534_abnormal_ureter_morphology | 0.55067110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.67215476 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.16770564 |
| 3 | Progressive macrocephaly (HP:0004481) | 3.93005881 |
| 4 | Acute encephalopathy (HP:0006846) | 3.82821293 |
| 5 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.62885926 |
| 6 | Mitochondrial inheritance (HP:0001427) | 3.55458595 |
| 7 | Pheochromocytoma (HP:0002666) | 3.53357346 |
| 8 | Neuroendocrine neoplasm (HP:0100634) | 3.46273630 |
| 9 | Hypothermia (HP:0002045) | 3.35786576 |
| 10 | Neurofibrillary tangles (HP:0002185) | 3.34624534 |
| 11 | Entropion (HP:0000621) | 3.31292762 |
| 12 | Hand muscle atrophy (HP:0009130) | 3.30983737 |
| 13 | Upper limb muscle weakness (HP:0003484) | 3.28112468 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 3.23628220 |
| 15 | Upper limb amyotrophy (HP:0009129) | 2.89725032 |
| 16 | Distal upper limb amyotrophy (HP:0007149) | 2.89725032 |
| 17 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.89074524 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.85166249 |
| 19 | Hypokinesia (HP:0002375) | 2.78627211 |
| 20 | Hepatocellular necrosis (HP:0001404) | 2.78082026 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.78079980 |
| 22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.78079980 |
| 23 | Difficulty climbing stairs (HP:0003551) | 2.77749031 |
| 24 | Type II lissencephaly (HP:0007260) | 2.73993170 |
| 25 | Increased CSF lactate (HP:0002490) | 2.71539829 |
| 26 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.69486052 |
| 27 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.69486052 |
| 28 | Abnormal protein glycosylation (HP:0012346) | 2.69486052 |
| 29 | Abnormal glycosylation (HP:0012345) | 2.69486052 |
| 30 | Cholecystitis (HP:0001082) | 2.63460612 |
| 31 | Abnormal gallbladder physiology (HP:0012438) | 2.63460612 |
| 32 | Methylmalonic acidemia (HP:0002912) | 2.61916622 |
| 33 | Sensory axonal neuropathy (HP:0003390) | 2.57983968 |
| 34 | Type I transferrin isoform profile (HP:0003642) | 2.57379877 |
| 35 | Cerebral edema (HP:0002181) | 2.53761371 |
| 36 | Short nail (HP:0001799) | 2.53382525 |
| 37 | Optic disc pallor (HP:0000543) | 2.52300766 |
| 38 | Abnormal pupillary function (HP:0007686) | 2.50961825 |
| 39 | Cerebral hemorrhage (HP:0001342) | 2.49926800 |
| 40 | Protrusio acetabuli (HP:0003179) | 2.49882340 |
| 41 | Generalized aminoaciduria (HP:0002909) | 2.49407803 |
| 42 | Cerebellar dysplasia (HP:0007033) | 2.49105369 |
| 43 | Increased cerebral lipofuscin (HP:0011813) | 2.48206476 |
| 44 | Premature rupture of membranes (HP:0001788) | 2.47633355 |
| 45 | Focal motor seizures (HP:0011153) | 2.47190392 |
| 46 | Ankle contracture (HP:0006466) | 2.46146286 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 2.45079227 |
| 48 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.43426035 |
| 49 | Leukodystrophy (HP:0002415) | 2.42604531 |
| 50 | Parakeratosis (HP:0001036) | 2.41907428 |
| 51 | Abnormality of glycolysis (HP:0004366) | 2.41658960 |
| 52 | Increased serum pyruvate (HP:0003542) | 2.41658960 |
| 53 | Hepatic necrosis (HP:0002605) | 2.41515781 |
| 54 | Atonic seizures (HP:0010819) | 2.40533882 |
| 55 | Autoamputation (HP:0001218) | 2.38959772 |
| 56 | Delusions (HP:0000746) | 2.38841253 |
| 57 | Renal Fanconi syndrome (HP:0001994) | 2.33429748 |
| 58 | Cerebral hypomyelination (HP:0006808) | 2.33000375 |
| 59 | Methylmalonic aciduria (HP:0012120) | 2.31446475 |
| 60 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.28092534 |
| 61 | Rough bone trabeculation (HP:0100670) | 2.28034783 |
| 62 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.26276045 |
| 63 | Cervical subluxation (HP:0003308) | 2.25375296 |
| 64 | Respiratory failure (HP:0002878) | 2.24279423 |
| 65 | Reduced antithrombin III activity (HP:0001976) | 2.22575257 |
| 66 | Atrophic scars (HP:0001075) | 2.21462680 |
| 67 | Follicular hyperkeratosis (HP:0007502) | 2.20775817 |
| 68 | Retinal dysplasia (HP:0007973) | 2.17456289 |
| 69 | Nuclear cataract (HP:0100018) | 2.17296069 |
| 70 | Mutism (HP:0002300) | 2.16229907 |
| 71 | Akinesia (HP:0002304) | 2.15616122 |
| 72 | Dysostosis multiplex (HP:0000943) | 2.14672171 |
| 73 | Emotional lability (HP:0000712) | 2.14457072 |
| 74 | Hyperventilation (HP:0002883) | 2.14010436 |
| 75 | Supranuclear gaze palsy (HP:0000605) | 2.09131878 |
| 76 | Congenital glaucoma (HP:0001087) | 2.08999057 |
| 77 | Polyphagia (HP:0002591) | 2.07293600 |
| 78 | Stridor (HP:0010307) | 2.05000165 |
| 79 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.02162311 |
| 80 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.02162311 |
| 81 | Abnormal hair whorl (HP:0010721) | 2.01569853 |
| 82 | Epiphyseal dysplasia (HP:0002656) | 2.00796147 |
| 83 | X-linked dominant inheritance (HP:0001423) | 1.99606312 |
| 84 | Spinal rigidity (HP:0003306) | 1.97306089 |
| 85 | Medial flaring of the eyebrow (HP:0010747) | 1.94910118 |
| 86 | Hypoplasia of the pons (HP:0012110) | 1.94396429 |
| 87 | Retinal atrophy (HP:0001105) | 1.93867894 |
| 88 | Abnormal trabecular bone morphology (HP:0100671) | 1.93135198 |
| 89 | Buphthalmos (HP:0000557) | 1.89861844 |
| 90 | Secondary amenorrhea (HP:0000869) | 1.88245175 |
| 91 | CNS demyelination (HP:0007305) | 1.87699020 |
| 92 | Split foot (HP:0001839) | 1.87575789 |
| 93 | Esotropia (HP:0000565) | 1.87570744 |
| 94 | Thickened helices (HP:0000391) | 1.80519986 |
| 95 | Progressive microcephaly (HP:0000253) | 1.80419473 |
| 96 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78713950 |
| 97 | Cortical visual impairment (HP:0100704) | 1.78105360 |
| 98 | Increased serum lactate (HP:0002151) | 1.77786839 |
| 99 | Disproportionate short-trunk short stature (HP:0003521) | 1.77672574 |
| 100 | CNS hypomyelination (HP:0003429) | 1.77543898 |
| 101 | Fatigue (HP:0012378) | 1.77423915 |
| 102 | Agitation (HP:0000713) | 1.77293682 |
| 103 | Limb-girdle muscle atrophy (HP:0003797) | 1.76679319 |
| 104 | Craniofacial dystonia (HP:0012179) | 1.73715002 |
| 105 | Abnormality of dentin (HP:0010299) | 1.73614446 |
| 106 | Myoclonus (HP:0001336) | 1.73310999 |
| 107 | Vaginal atresia (HP:0000148) | 1.73272802 |
| 108 | Gait imbalance (HP:0002141) | 1.73146413 |
| 109 | Abnormality of renal resorption (HP:0011038) | 1.72663335 |
| 110 | Bladder diverticulum (HP:0000015) | 1.72158142 |
| 111 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.71960880 |
| 112 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.71428083 |
| 113 | Redundant skin (HP:0001582) | 1.70863580 |
| 114 | Spastic paraparesis (HP:0002313) | 1.70829002 |
| 115 | Delayed gross motor development (HP:0002194) | 1.70300785 |
| 116 | Abnormal tarsal ossification (HP:0008369) | 1.69721963 |
| 117 | Limb dystonia (HP:0002451) | 1.69654417 |
| 118 | Symptomatic seizures (HP:0011145) | 1.69153740 |
| 119 | Poor suck (HP:0002033) | 1.69034666 |
| 120 | Abnormality of placental membranes (HP:0011409) | 1.68933697 |
| 121 | Amniotic constriction ring (HP:0009775) | 1.68933697 |
| 122 | Diminished movement (HP:0002374) | 1.68858915 |
| 123 | Exercise intolerance (HP:0003546) | 1.68385053 |
| 124 | Genital tract atresia (HP:0001827) | 1.68269269 |
| 125 | Metaphyseal dysplasia (HP:0100255) | 1.68053687 |
| 126 | Abnormality of glycolipid metabolism (HP:0010969) | 1.67156992 |
| 127 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.67156992 |
| 128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.67156992 |
| 129 | Delayed CNS myelination (HP:0002188) | 1.65957904 |
| 130 | Congenital primary aphakia (HP:0007707) | 1.65716259 |
| 131 | Cardiovascular calcification (HP:0011915) | 1.65667782 |
| 132 | Adrenal hypoplasia (HP:0000835) | 1.65593634 |
| 133 | Severe muscular hypotonia (HP:0006829) | 1.65326914 |
| 134 | Opisthotonus (HP:0002179) | 1.64506218 |
| 135 | Dialeptic seizures (HP:0011146) | 1.63941316 |
| 136 | Vertebral compression fractures (HP:0002953) | 1.63669766 |
| 137 | Absence seizures (HP:0002121) | 1.61744722 |
| 138 | Epileptic encephalopathy (HP:0200134) | 1.61380149 |
| 139 | Axonal loss (HP:0003447) | 1.61368003 |
| 140 | Abnormality of the pons (HP:0007361) | 1.61008410 |
| 141 | Increased intramyocellular lipid droplets (HP:0012240) | 1.60587442 |
| 142 | Mitral stenosis (HP:0001718) | 1.59105693 |
| 143 | Insomnia (HP:0100785) | 1.58648254 |
| 144 | Progressive neurologic deterioration (HP:0002344) | 1.58097852 |
| 145 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.57327821 |
| 146 | Hyperalaninemia (HP:0003348) | 1.57327821 |
| 147 | Beaking of vertebral bodies (HP:0004568) | 1.57326721 |
| 148 | Clumsiness (HP:0002312) | 1.57079495 |
| 149 | Nephrogenic diabetes insipidus (HP:0009806) | 1.56283254 |
| 150 | Prolonged neonatal jaundice (HP:0006579) | 1.56161268 |
| 151 | Xerostomia (HP:0000217) | 1.56045110 |
| 152 | Increased hepatocellular lipid droplets (HP:0006565) | 1.55765485 |
| 153 | Infantile muscular hypotonia (HP:0008947) | 1.53925322 |
| 154 | Conjugated hyperbilirubinemia (HP:0002908) | 1.53795369 |
| 155 | Lactic acidosis (HP:0003128) | 1.52998214 |
| 156 | Thyroid-stimulating hormone excess (HP:0002925) | 1.52788096 |
| 157 | Abnormality of urine glucose concentration (HP:0011016) | 1.51668957 |
| 158 | Glycosuria (HP:0003076) | 1.51668957 |
| 159 | Congenital sensorineural hearing impairment (HP:0008527) | 1.51316338 |
| 160 | Myokymia (HP:0002411) | 1.51304122 |
| 161 | 3-Methylglutaconic aciduria (HP:0003535) | 1.51136372 |
| 162 | Progressive inability to walk (HP:0002505) | 1.51128385 |
| 163 | Hypoglycemic seizures (HP:0002173) | 1.48438604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.32742459 |
| 2 | BCKDK | 3.19695888 |
| 3 | MST4 | 2.93169692 |
| 4 | STK39 | 2.85441969 |
| 5 | TESK2 | 2.77479421 |
| 6 | OXSR1 | 2.52670111 |
| 7 | MAP3K12 | 2.41050858 |
| 8 | EPHB2 | 2.36250252 |
| 9 | MAP4K2 | 2.27973132 |
| 10 | NME1 | 2.21561066 |
| 11 | EPHA2 | 2.09829691 |
| 12 | ARAF | 2.07181459 |
| 13 | MYLK | 2.02933749 |
| 14 | BCR | 2.02048778 |
| 15 | WNK4 | 1.99961175 |
| 16 | DDR2 | 1.99040820 |
| 17 | LIMK1 | 1.92067368 |
| 18 | VRK2 | 1.86014054 |
| 19 | NTRK1 | 1.83648421 |
| 20 | STK10 | 1.77084619 |
| 21 | BMPR1B | 1.71764255 |
| 22 | EPHB1 | 1.61203977 |
| 23 | LMTK2 | 1.59218150 |
| 24 | PRPF4B | 1.57576830 |
| 25 | WNK3 | 1.52860614 |
| 26 | TRIM28 | 1.49983860 |
| 27 | AKT3 | 1.42035525 |
| 28 | CAMK2B | 1.39869707 |
| 29 | ADRBK2 | 1.38097276 |
| 30 | GRK7 | 1.37219437 |
| 31 | NTRK3 | 1.35920181 |
| 32 | ERBB4 | 1.32340766 |
| 33 | INSRR | 1.31696011 |
| 34 | BLK | 1.31568992 |
| 35 | PAK4 | 1.31031960 |
| 36 | PBK | 1.27934842 |
| 37 | CDK19 | 1.25936119 |
| 38 | PLK2 | 1.24664824 |
| 39 | TNIK | 1.22558008 |
| 40 | CAMK2D | 1.21183801 |
| 41 | GRK5 | 1.17547619 |
| 42 | NEK6 | 1.14692150 |
| 43 | BMPR2 | 1.13948612 |
| 44 | PAK3 | 1.13781363 |
| 45 | PRKCE | 1.13147419 |
| 46 | PAK6 | 1.11871380 |
| 47 | MAPKAPK5 | 1.10890929 |
| 48 | PIK3CA | 1.10260771 |
| 49 | MAPK15 | 1.09986553 |
| 50 | CAMK2A | 1.07283158 |
| 51 | MET | 1.05546259 |
| 52 | MAP3K11 | 1.01861369 |
| 53 | PIM2 | 0.99785591 |
| 54 | SRPK1 | 0.99270549 |
| 55 | CAMK2G | 0.97871005 |
| 56 | FER | 0.96986019 |
| 57 | CSNK1G3 | 0.96590937 |
| 58 | MAP2K7 | 0.96481359 |
| 59 | TBK1 | 0.95826710 |
| 60 | PIK3CG | 0.95614814 |
| 61 | STK16 | 0.95449676 |
| 62 | PTK2B | 0.93984629 |
| 63 | PKN1 | 0.93706190 |
| 64 | NEK1 | 0.93376750 |
| 65 | MAP3K3 | 0.91691990 |
| 66 | ROCK2 | 0.91386201 |
| 67 | SIK3 | 0.89690466 |
| 68 | BRAF | 0.89450235 |
| 69 | TAOK2 | 0.88920456 |
| 70 | AURKA | 0.88261359 |
| 71 | FGR | 0.82823523 |
| 72 | BUB1 | 0.82658510 |
| 73 | EPHA4 | 0.82599553 |
| 74 | DAPK1 | 0.82429973 |
| 75 | CAMKK2 | 0.82286197 |
| 76 | MAP2K1 | 0.82206857 |
| 77 | PRKD3 | 0.81863252 |
| 78 | MAPKAPK3 | 0.80979691 |
| 79 | PDK2 | 0.80759207 |
| 80 | ILK | 0.79637694 |
| 81 | WNK1 | 0.77321772 |
| 82 | TRPM7 | 0.76843310 |
| 83 | DAPK3 | 0.76425605 |
| 84 | SGK494 | 0.74695682 |
| 85 | SGK223 | 0.74695682 |
| 86 | EIF2AK3 | 0.73064394 |
| 87 | MAP3K2 | 0.71841283 |
| 88 | MAP3K4 | 0.70939978 |
| 89 | CSNK1G2 | 0.70367306 |
| 90 | FRK | 0.68790486 |
| 91 | PAK1 | 0.67264987 |
| 92 | OBSCN | 0.66770432 |
| 93 | ADRBK1 | 0.66639770 |
| 94 | TESK1 | 0.66525759 |
| 95 | FGFR2 | 0.66084998 |
| 96 | MARK1 | 0.64205893 |
| 97 | MINK1 | 0.63317637 |
| 98 | DYRK2 | 0.62700308 |
| 99 | ERN1 | 0.62379322 |
| 100 | PRKCI | 0.61762271 |
| 101 | EIF2AK1 | 0.60409749 |
| 102 | CDK5 | 0.59710104 |
| 103 | PRKCG | 0.59687484 |
| 104 | PTK2 | 0.59352254 |
| 105 | MAP2K2 | 0.58753640 |
| 106 | MAP3K5 | 0.58183799 |
| 107 | MUSK | 0.57873802 |
| 108 | MST1R | 0.57243449 |
| 109 | PRKD2 | 0.56961241 |
| 110 | FLT3 | 0.56779808 |
| 111 | NME2 | 0.56579993 |
| 112 | CSNK1A1L | 0.56405809 |
| 113 | FES | 0.56177849 |
| 114 | ABL2 | 0.54691630 |
| 115 | CSNK1G1 | 0.54451443 |
| 116 | DAPK2 | 0.54442339 |
| 117 | PRKG2 | 0.53400120 |
| 118 | GRK1 | 0.52337800 |
| 119 | KDR | 0.51438751 |
| 120 | TGFBR2 | 0.50922847 |
| 121 | MOS | 0.49312580 |
| 122 | PNCK | 0.49192995 |
| 123 | CDK18 | 0.47143591 |
| 124 | PINK1 | 0.46410432 |
| 125 | TLK1 | 0.46284990 |
| 126 | MAP3K9 | 0.46152397 |
| 127 | CDK11A | 0.45816002 |
| 128 | CDK14 | 0.45456109 |
| 129 | PRKACA | 0.43515297 |
| 130 | ROCK1 | 0.43452700 |
| 131 | FYN | 0.43104063 |
| 132 | BRSK1 | 0.42728195 |
| 133 | AKT2 | 0.42264823 |
| 134 | MAPK13 | 0.41984021 |
| 135 | PHKG2 | 0.41853700 |
| 136 | PHKG1 | 0.41853700 |
| 137 | CSK | 0.40997434 |
| 138 | ERBB3 | 0.40927037 |
| 139 | UHMK1 | 0.40729135 |
| 140 | IRAK3 | 0.40602475 |
| 141 | PAK2 | 0.40107995 |
| 142 | CDK15 | 0.39735728 |
| 143 | GSK3A | 0.39585822 |
| 144 | PRKCQ | 0.39195244 |
| 145 | TAOK1 | 0.38426186 |
| 146 | CSNK1A1 | 0.37880774 |
| 147 | MAP2K4 | 0.37406382 |
| 148 | CCNB1 | 0.35326811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 4.05458520 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.96399549 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.26077231 |
| 4 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 3.01995584 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 2.75476696 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.71737914 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.70247011 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.49130769 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.37818016 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.22515415 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.21544946 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.12581606 |
| 13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.11679061 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.01569152 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.87016902 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 1.83054462 |
| 17 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.79301050 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.78078881 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71851761 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.67558198 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.66317606 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.62911642 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.57753557 |
| 24 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.55786490 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.55339565 |
| 26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.52229125 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.51318577 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.51032676 |
| 29 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.48471295 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.47389914 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43053954 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.35908074 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.34104192 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.32267366 |
| 35 | Proteasome_Homo sapiens_hsa03050 | 1.30840450 |
| 36 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.26701845 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.22643622 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.22419292 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20268952 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 1.19971470 |
| 41 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.15434243 |
| 42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15122731 |
| 43 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.14364341 |
| 44 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12742782 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.11676230 |
| 46 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11180371 |
| 47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.10192843 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05751189 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.04632449 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03615516 |
| 51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.02159082 |
| 52 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97750491 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96425247 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96113526 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.93916933 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93350891 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93009121 |
| 58 | Taste transduction_Homo sapiens_hsa04742 | 0.92428118 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.90866526 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90322968 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88896290 |
| 62 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.87764995 |
| 63 | Morphine addiction_Homo sapiens_hsa05032 | 0.85524246 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77894576 |
| 65 | * Cocaine addiction_Homo sapiens_hsa05030 | 0.76801365 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.76728381 |
| 67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75431143 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74144393 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71246155 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.70122968 |
| 71 | * Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70118752 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69396991 |
| 73 | * Insulin secretion_Homo sapiens_hsa04911 | 0.68109341 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.67112111 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66977181 |
| 76 | Axon guidance_Homo sapiens_hsa04360 | 0.64096415 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63618514 |
| 78 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.63057033 |
| 79 | Base excision repair_Homo sapiens_hsa03410 | 0.63038501 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.62851527 |
| 81 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 0.62041050 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61543734 |
| 83 | Circadian entrainment_Homo sapiens_hsa04713 | 0.59884400 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.59311525 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58983129 |
| 86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58590473 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58113936 |
| 88 | Legionellosis_Homo sapiens_hsa05134 | 0.57768136 |
| 89 | Purine metabolism_Homo sapiens_hsa00230 | 0.57472642 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57194444 |
| 91 | Long-term depression_Homo sapiens_hsa04730 | 0.56941605 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.56657406 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54758018 |
| 94 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.54756039 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54525364 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53737647 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52362591 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52325389 |
| 99 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51543915 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51215241 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50029753 |
| 102 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48376305 |
| 103 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.48074991 |
| 104 | Malaria_Homo sapiens_hsa05144 | 0.47986213 |
| 105 | * Amphetamine addiction_Homo sapiens_hsa05031 | 0.47533944 |
| 106 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47110735 |
| 107 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46962677 |
| 108 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45945351 |
| 109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45747619 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45463998 |
| 111 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.45311462 |
| 112 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43921035 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.43764083 |
| 114 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43094857 |
| 115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42077957 |
| 116 | * Cholinergic synapse_Homo sapiens_hsa04725 | 0.40837553 |
| 117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39584699 |
| 118 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37135710 |
| 119 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.36162994 |
| 120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35350771 |
| 121 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32843384 |
| 122 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.31828605 |
| 123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31490773 |
| 124 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.31347698 |
| 125 | Basal transcription factors_Homo sapiens_hsa03022 | 0.30914278 |
| 126 | Phototransduction_Homo sapiens_hsa04744 | 0.30848312 |
| 127 | Salmonella infection_Homo sapiens_hsa05132 | 0.30378959 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.30073569 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29393199 |
| 130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29095976 |
| 131 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28879394 |
| 132 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.27986594 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27180120 |
| 134 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26583913 |
| 135 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.26164757 |
| 136 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26093401 |
| 137 | Focal adhesion_Homo sapiens_hsa04510 | 0.25325006 |
| 138 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25076180 |
| 139 | Salivary secretion_Homo sapiens_hsa04970 | 0.24959356 |
| 140 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.24458681 |
| 141 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.24287901 |
| 142 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.23135909 |

